Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14 — Neutral
APDN Accesswire — February 11, 2025STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to its shareholders to vote ahead of a reconvening of a Special Meeting of Stockholders (the "Special Meeting") to be held on Friday, February 14, 2025 at 11:00 a.m. The Company's Board of Directors encourages any shareholder as of the record date of November 25, 2024, who has not yet voted their shares on the Warrant Exercise Proposal (as defined below), to contact Kingsdale Advisors to vote their shares: …
Venture Global, Inc. Being Investigated on Behalf of Venture Global, Inc. Investors. Contact Levi & Korsinsky For Details — Neutral
VG Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Venture Global, Inc. ("Venture Global, Inc.") (NYSE:VG) concerning possible violations of federal securities laws. Venture Global conducted its initial public offering of 70 million shares priced at $25.00 per share on or around January 24, 2025.
Gladstone Investment Corporation Earnings Call and Webcast Information — Neutral
GAIN Accesswire — February 11, 2025MCLEAN, VA / ACCESS Newswire / February 11, 2025 / Gladstone Investment Corporation (Nasdaq:GAIN) announces the following event: What: Gladstone Investment Corporation's Third Fiscal Quarter Ended December 31, 2024 Earnings Call & Webcast When: Thursday, February 13, 2025 @ 8:30 a.m. ET Where: https://event.choruscall.com/mediaframe/webcast.html?webcastid=g3DvLY9j How: By webcast -- Log on to the web at the address above By phone -- please call (866) 424-3437 Contact: Gladstone Investment Corporation, (703) 287-5893 A conference call replay will be available beginning one hour after the call and will be accessible through February 20, 2025.
TSMC remains a top AI investment due to its dominant market position, strategic alliances, and cutting-edge technologies, despite geopolitical risks. In the long term, I expect to see TSMC's key margins stay where they are now (on a seasonality-adjusted basis) and probably even go up slightly. OpenAI's partnership with TSMC for in-house AI chip fabrication is a strong bullish sign, reinforcing my conviction.
Dominari Holdings Inc. Announces $13.5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules and Declares Special Cash Dividend — Neutral
DOMH Accesswire — February 11, 2025NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company" or "Dominari") today announced that it has entered into definitive securities purchase agreements with certain investors for 1,439,467 shares of its common stock, Series A warrants ("Series A Warrants") to purchase up to 1,439,467 shares of common stock and Series B warrants ("Series B Warrants", together with the Series A Warrants, the "Warrants") to purchase up to 1,439,467 shares of common stock at a combined purchase price of $3.47 per share and accompanying Warrants in a registered direct offering priced at-the-market under …
Persistent Pests: Miami, Los Angeles and Tampa Face Highest Termite Activity for Third Year Straight — Neutral
ROL PRNewsWire — February 11, 2025Orkin Shares What Homeowners Need to Know to Help Prevent Costly Damage ATLANTA , Feb. 11, 2025 /PRNewswire/ -- Miami remains the most termite-infested city in America, according to Orkin's Top 50 Termite Cities list. Los Angeles and Tampa , Fla.
Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month — Neutral
MYNZ GlobeNewsWire — February 11, 2025BERKELEY, Calif. and MAINZ, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V.
Centrus Energy Hits Critical Mass for Atomic Short-Squeeze — Positive
LEU MarketBeat — February 11, 2025The market for Centrus Energy NYSE: LEU has reached a critical mass, and an atomic short-squeeze is on. The market has already risen more than 50% this year and could increase by another 25% to 35% if the critical resistance point is breached.
Polaris: Ultimate Contrarian Bet That Pays Big Dividends — Positive
PII Seeking Alpha — February 11, 2025Polaris presents a contrarian investment opportunity with a historically high 6% dividend yield. It could be nearing a trough with management's focus on cost efficiencies, inventory alignment, and disciplined capital allocation with strong free cash flow expected this year. Polaris maintains a solid investment grade rating and a manageable 3.0x net debt-to-EBITDA ratio, supporting its financial stability.
American Rebel Holdings, Inc. (NASDAQ: AREB) Regains Compliance with NASDAQ Listing Standards as of February 10, 2025. — Neutral
AREB GlobeNewsWire — February 11, 2025Nashville, Tennessee, Feb. 11, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel (americanrebel.com), is pleased to announce that it has regained compliance with the periodic filing requirement under NASDAQ's listing rules.
FangDD Announces US$5,000,000 Senior Convertible Notes Offering — Neutral
DUO GlobeNewsWire — February 11, 2025SHENZHEN, China, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”), a customer-oriented property technology company in China, today announced that it has entered into a securities purchase agreement with certain investors (the “Purchase Agreement”) for the offering by the Company of (i) senior 5% original issue discount convertible promissory notes in an aggregate principal amount of US$5,000,000 (the “Notes”), (ii) Class A ordinary shares, par value US$0.0005625 per share, issuable from time to time upon conversion under the Notes, and (iii) additional 164,610 Class A ordinary shares in connection with the issuance …
Bitdeer Announces Fourth Quarter and Full Year 2024 Earnings Conference Call for February 25, 2025 — Neutral
BTDR GlobeNewsWire — February 11, 2025SINGAPORE, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for blockchain and high-performance computing, today announced that it has scheduled its fourth quarter and full year 2024 earnings conference call and webcast for Tuesday, February 25, 2025 at 8:00 AM EST. During the call, Bitdeer management will discuss the preliminary and unaudited financial and operational results for the quarter and year ended December 31, 2024, followed by a question-and-answer session.
LightSolver Partners With Ansys to Accelerate CAE Modelling for Automotive and Other Key Industries — Neutral
ANSS GlobeNewsWire — February 11, 2025TEL AVIV, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) -- LightSolver , inventors of a new laser-based computing paradigm, today announced a partnership with Ansys (NASDAQ: ANSS), a leading provider of engineering simulation software. Following a successful test run on LightSolver's platform, the two companies are working to integrate LightSolver's technology with Ansys LS-DYNA® nonlinear dynamics structural simulation software to accelerate simulations for automotive, aerospace, and other industries.
Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors — Neutral
SOLV GlobeNewsWire — February 11, 2025BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced the appointment of Elizabeth Mily to its Board of Directors as Independent Director. A highly respected healthcare and financial industry veteran with more than 30 years of experience, Mily brings extensive expertise in corporate strategy, business development and investment leadership to Ampersand as it advances its Address, Navigate, Determine (AND)™ Platform to develop programmed biologics.
LM Funding America Announces January 2025 Production and Operational Update — Neutral
LMFA GlobeNewsWire — February 11, 2025- 15 MW Oklahoma Mining Site Fully Operational - Bitcoin HODL valued at $16.1 million as of January 31, 2025 TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin mining and technology-based specialty finance company, today announced its preliminary, unaudited Bitcoin mining and operational update for the month ended January 31, 2025.
ABM Launches New Brand Platform Reinforcing Transformation as an Innovative and Tech-Enabled Solutions Provider — Neutral
ABM GlobeNewsWire — February 11, 2025NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- ABM (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, has unveiled its new brand platform: “Driving possibility, together.” This new positioning emphasizes ABM's evolution as a future-focused, innovative client partner, making spaces smarter, modernizing infrastructure, and transforming facilities to become more resilient.
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025 — Neutral
MIST GlobeNewsWire — February 11, 2025MONTREAL and CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced further details on its in-person and virtual Commercial Launch Plan investor event to take place in New York on Tuesday, February 25, 2025 from 10:30 AM to 12:30 PM ET.
Baby Boomers and Gen X Responsible for Increased Betting Activity in Q4 2024 — Neutral
TRU GlobeNewsWire — February 11, 2025CHICAGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Betting activity increased slightly in Q4 2024 to 26% of consumers, compared to 24% in the same period of 2023. However, this uptick was caused by significant generational changes in activity, primarily among Baby Boomers and Millennials, according to a new report from TransUnion (NYSE: TRU).
Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy — Neutral
LEXX Accesswire — February 11, 2025Additions broaden DehydraTECH patent suite for Epilepsy KELOWNA, BC / ACCESS Newswire / February 11, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that we have been granted two new patents from the United States Patent and Trademark Office for the use of DehydraTECH™ enhanced processing technology related to the treatment of epilepsy. "We are thrilled to have received broadened claims related to our proprietary DehydraTECH™ technology for the treatment of epilepsy," said Rich Christopher, CEO of Lexaria.
Jerash Holdings Reports Fiscal 2025 Third Quarter Financial Results — Neutral
JRSH Accesswire — February 11, 2025FAIRFIELD, NJ / ACCESS Newswire / February 11, 2025 / Jerash Holdings (US), Inc. ("Jerash" or the "Company") (NASDAQ:JRSH), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, today announced financial results for its fiscal 2025 third quarter, ended December 31, 2024. "While revenue increased by nearly 30 percent for the fiscal third quarter, results were lower than originally anticipated," Sam Choi, Jerash's chairman and chief executive officer, said.